Table 4.

eGFR (milliliters per minute per 1.73 m²) by MDRD at baseline and 6, 12, and 18 months stratified by baseline eGFR

Mean (SEM) eGFR, ml/min per 1.73 m2	RTX Group (n=51)	CYC/AZA Group (n=51)	P Value
Baseline eGFR>60	9	10
Baseline	80.1 (8.40)	76.6 (6.01)	0.74
6 mo	78.7 (7.50)	76.4 (5.33)	0.81
12 mo	77.3 (6.84)	76.2 (4.80)	0.90
18 mo	75.9 (6.52)	76.0 (4.46)	0.99
Comparison between 18 mo and baseline, P value	<0.01	0.20
Treatment difference over time, P value			0.54
Baseline eGFR=30–60	24	20
Baseline	39.5 (2.10)	46.6 (2.31)	0.03
6 mo	42.9 (2.49)	50.5 (2.72)	0.05
12 mo	46.4 (3.24)	54.4 (3.51)	0.10
18 mo	49.9 (4.16)	58.3 (4.50)	0.18
Comparison between 18 mo and baseline, P value	<0.01	<0.01
Treatment difference over time, P value			0.80
Baseline eGFR<30	18	14
Baseline	24.4 (1.66)	25.5 (1.88)	0.66
6 mo	26.3 (2.22)	28.0 (2.50)	0.61
12 mo	28.1 (3.32)	30.5 (3.73)	0.64
18 mo	30.0 (4.58)	33.0 (5.14)	0.67
Comparison between 18 mo and baseline, P value	<0.01	0.09
Treatment difference over time, P value			0.77